PHRI’s Director of Statistics and Senior Scientist, Shrikant I. Bangdiwala, PhD, and a Professor, Department of Health Research Methods, Evidence, and Impact, McMaster University, has been named as a member of the USA NIH National Institute of Allergy and Infectious Diseases (NIAID) COVID-19 Preventive mAb Data and Safety Monitoring Board (DSMB).

Dr Shrikant Bangdiwala

Shrikant Bangdiwala

The DSMB will be reviewing and monitoring, and evaluating the ongoing safety and efficacy of data from US government-supported clinical trials of candidate preventive monoclonal Antibodies for SARS-CoV-2 and COVID-19.

Composed of individuals from a variety of disciplines and includes clinicians, ethicists, statisticians, and other scientists, the recommendations of the DSMB will have important implications for public health on a global scale. The first meeting of the DSMB was on July 1st, 2020.

Back To Top